Biondo Investment Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,750
| Closed | -$1.3M | – | 83 |
|
|
2023
Q2 | $1.3M | Buy |
12,750
+9,200
| +259% | +$938K | 0.24% | 53 |
|
|
2023
Q1 | $323K | Buy |
+3,550
| New | +$323K | 0.07% | 67 |
|
|
2021
Q4 | – | Sell |
-104,120
| Closed | -$10.5M | – | 88 |
|
|
2021
Q3 | $10.5M | Buy |
104,120
+2,801
| +3% | +$282K | 1.8% | 18 |
|
|
2021
Q2 | $14.3M | Buy |
101,319
+115
| +0.1% | +$16.3K | 2.46% | 12 |
|
|
2021
Q1 | $10.1M | Sell |
101,204
-12,488
| -11% | -$1.25M | 2.01% | 17 |
|
|
2020
Q4 | $14.1M | Buy |
113,692
+14,040
| +14% | +$1.74M | 2.69% | 10 |
|
|
2020
Q3 | $9.71M | Buy |
99,652
+50
| +0.1% | +$4.87K | 2.1% | 13 |
|
|
2020
Q2 | $15.5M | Buy |
99,602
+12,030
| +14% | +$1.88M | 3.92% | 8 |
|
|
2020
Q1 | $12.6M | Sell |
87,572
-2,563
| -3% | -$370K | 4.19% | 7 |
|
|
2019
Q4 | $18.4M | Buy |
90,135
+16,580
| +23% | +$3.39M | 4.25% | 4 |
|
|
2019
Q3 | $5.91M | Buy |
73,555
+465
| +0.6% | +$37.3K | 1.51% | 19 |
|
|
2019
Q2 | $6.9M | Buy |
+73,090
| New | +$6.9M | 1.64% | 16 |
|